Enanta Pharmaceuticals, Inc. (ENTA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$13.41
Day's range
$14.03

Enanta Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANUS HENDERSON GROUP PLC 05/18/2026 3.78 M $47.72 M   1.46% 17.70%
BLACKROCK, INC. 05/13/2026 3.10 M $39.20 M   0.89% 14.52%
FARALLON CAPITAL MANAGEMENT LLC 05/15/2026 2.87 M $36.27 M   3.59% 13.43%
KRENSAVAGE ASSET MANAGEMENT, LLC 05/15/2026 2.87 M $36.20 M   3.61% 13.41%
DEEP TRACK CAPITAL, LP 05/15/2026 1.96 M $24.72 M   0.00% 9.15%
05/15/2026 1.18 M $14.88 M   100.00% 5.51%
05/08/2026 948.90 K $11.98 M   100.00% 4.44%
05/14/2026 932.60 K $11.78 M   139.32% 4.36%
MILLENNIUM MANAGEMENT LLC 05/15/2026 882.10 K $11.14 M   31.57% 4.13%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 880.02 K $11.10 M   -0.58% 4.12%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 725.06 K $9.16 M   12.27% 3.39%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 665.26 K $8.40 M   3.59% 3.11%
STATE STREET CORP 05/15/2026 562.11 K $7.10 M   7.33% 2.63%
HILLSDALE INVESTMENT MANAGEMENT INC. 05/04/2026 435.51 K $5.50 M   3.13% 2.04%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 313.16 K $3.96 M   33.35% 1.46%
MORGAN STANLEY 05/15/2026 309.51 K $3.91 M   -8.95% 1.45%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 294.97 K $3.73 M   34.91% 1.38%
TWO SIGMA INVESTMENTS, LP 05/15/2026 267.36 K $3.38 M   -6.34% 1.25%
GOLDMAN SACHS GROUP INC 05/15/2026 265.09 K $3.35 M   21.15% 1.24%
CITADEL ADVISORS LLC 05/15/2026 262.53 K $3.32 M   181.81% 1.23%
NORTHERN TRUST CORP 05/14/2026 240.97 K $3.04 M   4.82% 1.13%
MARSHALL WACE, LLP 05/15/2026 210.07 K $2.65 M   -45.48% 0.98%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 203.25 K $2.57 M   -3.95% 0.95%
INVESCO LTD. 05/12/2026 182.00 K $2.30 M   -28.29% 0.85%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 175.86 K $2.22 M   100.00% 0.82%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 125.76 K $1.59 M   21.04% 0.59%
OPALEYE MANAGEMENT INC. 05/15/2026 125.00 K $1.58 M   66.67% 0.58%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 116.96 K $1.48 M   261.11% 0.55%
SEI INVESTMENTS CO 05/13/2026 109.08 K $1.38 M   10.42% 0.51%
JPMORGAN CHASE & CO 05/13/2026 103.06 K $1.26 M   -8.77% 0.48%
PANAGORA ASSET MANAGEMENT INC 05/14/2026 89.60 K $1.13 M   33.75% 0.42%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 74.96 K $946.75 K   18.57% 0.35%
RUSSELL INVESTMENTS GROUP, LTD. 05/08/2026 72.85 K $914.76 K   534.42% 0.34%
D. E. SHAW & CO., INC. 05/15/2026 70.88 K $895.27 K   -57.74% 0.33%
BANK OF NEW YORK MELLON CORP 05/05/2026 70.78 K $893.99 K   -2.49% 0.33%
FRANKLIN RESOURCES INC 05/13/2026 66.95 K $845.54 K   104.61% 0.31%
DIADEMA PARTNERS LP 05/15/2026 64.95 K $820.34 K   -0.29% 0.30%
UBS GROUP AG 05/05/2026 63.80 K $805.84 K   1,153.02% 0.30%
TREXQUANT INVESTMENT LP 05/15/2026 56.17 K $709.39 K   100.00% 0.26%
NUVEEN, LLC 04/30/2026 52.27 K $660.17 K   -39.26% 0.24%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 51.36 K $648.64 K   24.18% 0.24%
EAM INVESTORS, LLC 05/13/2026 40.95 K $517.22 K   0.00% 0.19%
CAMPBELL & CO INVESTMENT ADVISER LLC 05/15/2026 40.21 K $507.90 K   -25.73% 0.19%
SIO CAPITAL MANAGEMENT, LLC 05/14/2026 40.00 K $505.20 K   0.00% 0.19%
MAN GROUP PLC 05/15/2026 39.23 K $495.53 K   -10.52% 0.18%
IEQ CAPITAL, LLC 05/15/2026 38.67 K $488.43 K   6.29% 0.18%
PRUDENTIAL FINANCIAL INC 05/13/2026 38.00 K $479.88 K   -5.05% 0.18%
QUANTINNO CAPITAL MANAGEMENT LP 05/15/2026 35.12 K $443.59 K   4.86% 0.16%
BANK OF MONTREAL /CAN/ 05/13/2026 33.87 K $427.75 K   -9.65% 0.16%
ALLIANCEBERNSTEIN L.P. 05/15/2026 33.74 K $532.08 K   0.00% 0.16%

Enanta Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 200 institutional investors and hedge funds held shares of Enanta Pharmaceuticals Inc. The most heavily invested institutionals were:

JANUS HENDERSON GROUP PLC: 3.78 M

BlackRock, Inc.: 3.1 M

FARALLON CAPITAL MANAGEMENT LLC: 2.87 M

Krensavage Asset Management, LLC: 2.87 M

Deep Track Capital, LP: 1.96 M

MILLENNIUM MANAGEMENT LLC: 882,097

125.22% of Enanta Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 33.07 M shares in the last 24 months. This purchase volume represents approximately $459.40 M in transactions.